Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase.
In a continuous line of rat thyroid cells transformed by the k-ras oncogene (KiKi), the expression of ras-p21 correlates with an increased activity of a phosphoinositide-specific phospholipase A2, which leads to elevated levels of glycerophosphoinositols. In this study we have characterized the biological activities of these compounds. Growth and differentiation in thyroid cells are mainly regulated by the activation of adenylylcyclase. Therefore, we have studied the effects of glycerophosphoinositols on the activity of this enzyme using a normal thyroid cell line (FRTL5). Micromolar concentrations of glycerophosphoinositol 4-phosphate (GroPIns-4-P) caused a approximately 50% inhibition of the adenylylcyclase activity in FRTL5 membranes stimulated by the GTP-binding protein activator fluoroaluminate. Similar concentrations of GroPIns-4-P were detected in KiKi cells but not in the normal FRTL5 line. Micromolar GroPIns-4-P was found to be taken up by intact FRTL5 cells and to induce nearly 50% inhibition of the thyrotropin- and cholera toxin-induced increase in cAMP levels. Similar results were also observed in other cell lines (smooth muscle, pituitary cells, and pneumocytes). GroPIns-4-P inhibited cAMP-dependent cellular functions such as iodide uptake and thymidine incorporation in FRTL5 cells when stimulated by thyrotropin and cholera toxin but not when induced by forskolin. These results are consistent with GroPIns-4-P exerting an inhibitory effect on the GTP-binding protein that stimulates adenylycyclase. We propose that GroPIns-4-P might mediate a mechanism of cross-talk between adenylylcyclase and phospholipase A2 in thyroid as well as in other cell systems.
Iacovelli
L
L
Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Laboratory of Cellular and Molecular Endocrinology, Chieti, Italy.
Falasca
M
M
Valitutti
S
S
D'Arcangelo
D
D
Corda
D
D
D000246:Adenosine Diphosphate Ribose / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000302:isolation & purification*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002460:Cell Line; D002461:Cell Line, Transformed; D002462:Cell Membrane / Q000201:enzymology; D002772:Cholera Toxin / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D000242:Cyclic AMP / Q000378:metabolism*; D004247:DNA / Q000096:biosynthesis; D004261:DNA Replication; D011905:Genes, ras; D007294:Inositol / Q000378:metabolism; D007295:Inositol Phosphates; D007454:Iodides / Q000378:metabolism; D010716:Phosphatidylinositols / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D016283:Proto-Oncogene Proteins p21(ras) / Q000096:biosynthesis*; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D013961:Thyroid Gland; D014316:Tritium
D007295:Inositol Phosphates; D007454:Iodides; D010716:Phosphatidylinositols; D014316:Tritium; C062528:glycero-3-phosphoinositol 4-phosphate; D000246:Adenosine Diphosphate Ribose; D007294:Inositol; D004247:DNA; D002772:Cholera Toxin; D000242:Cyclic AMP; D011065:Poly(ADP-ribose) Polymerases; D010741:Phospholipases A; D054467:Phospholipases A2; D016283:Proto-Oncogene Proteins p21(ras); D000262:Adenylyl Cyclases; D013936:Thymidine